Immuno-cell therapy of cancer in Japan.
The immuno-cell therapy of cancer in Japan is in the phase of transition from therapeutic research to a more generalized option for all patients. A short history of cancer immunotherapy in Japan and its present status are summarized. In 1999, the first private clinic with a cell processing facility and specializing in immuno-cell therapy was established. Since then, the number of such clinics has increased. As a result, the number of patients who undergone the therapy has markedly increased. A summary of the clinical results of the therapy in 1401 patients treated in two leading clinics is also presented.
Egawa
Kohji
K
Japan Research Association of Immunotherapeutics and 2Seta Clinic, 4-20-18 Seta, Setagayaku, Tokyo 158-0095, Japan. egawa@j-immunother.com
D003131:Combined Modality Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000639:trends; D007564:Japan; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy*